U.S. Physical Therapy, Inc. (USPH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $1.49B
Last updated: Nov 17, 2026 at 4:10 PM ET
U.S. Physical Therapy, Inc. (USPH) Statistics
U.S. Physical Therapy (USPH) has a market cap of $1.49B and an enterprise value of $1.69B. Its trailing P/E is 36.3x.
Total Valuation
Enterprise value is 13.99% above the market cap, as debt exceeds cash.
| Market Cap | $1.49B |
|---|---|
| Enterprise Value | $1.69B |
| Latest price (Nov 17, 2026) | $97.39 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 16, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Last Ex-Dividend Date | Nov 16, 2026 |
| Next Payment Date | Dec 11, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.7x and 3.4x. Its year-end P/E ranged from 29.8x to 50.3x from 2016 to 2025.
| P/E Ratio | 36.3x |
|---|---|
| Forward P/E | 33.3x |
| P/S Ratio | 1.7x |
| Forward P/S | 1.7x |
| P/B Ratio | 3.4x |
| P/FCF Ratio | 21.0x |
| P/OCF Ratio | 16.7x |
| PEG Ratio | 3.0 |
Enterprise Valuation
Counting debt and cash, the company is valued at 16.6x EBITDA and 24.0x free cash flow.
| EV / Earnings | 34.0x |
|---|---|
| EV / Sales | 2.0x |
| EV / EBITDA | 16.6x |
| EV / EBIT | 22.1x |
| EV / FCF | 24.0x |
Price Statistics
The stock is up 37.58% over 52 weeks and trades 12.39% above its 50-day average.
| Beta (1Y) | 0.25 |
|---|---|
| 52-Week Change | +37.58% |
| 1-Month Change | +16.60% |
| 3-Month Change | +24.25% |
| 6-Month Change | +60.19% |
| 5-Year Change | -20.42% |
| 10-Year Change | +50.84% |
| Total Return (1Y) | +40.18% |
| Total Return (3Y CAGR) | +6.01% |
| Total Return (5Y CAGR) | +1.86% |
| Return vs SPY (1Y) | +30.55% |
| Max Drawdown (1Y) | -33.05% |
| Max Drawdown (3Y) | -46.77% |
| Sharpe Ratio (1Y) | 0.92 |
| Correlation with SPY (1Y) | 0.09 |
| 50-Day Average | $86.65 |
| 200-Day Average | $76.73 |
| 52-Week Range | $57.16 to $101.33 |
| RSI (14 Days) | 65.0 |
| Average Volume (20 Days) | 197.21K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.42x current liabilities, and total debt is 0.57x shareholder equity.
| Current Ratio | 1.42x |
|---|---|
| Quick Ratio | 1.42x |
| Debt / Equity | 0.57x |
| Debt / EBITDA | 2.47x |
| Debt / FCF | 3.56x |
| Interest Coverage | 6.35x |
Returns and Efficiency
Return on invested capital is 8.54% over the last 12 months, against a 5-year average of 9.51%.
| Return on Equity (ROE) | 11.60% |
|---|---|
| Return on Assets (ROA) | 3.84% |
| Return on Invested Capital (ROIC) | 8.54% |
| Return on Capital Employed (ROCE) | 6.45% |
| ROE (5Y Average) | 12.53% |
| ROA (5Y Average) | 5.05% |
| ROIC (5Y Average) | 9.51% |
| Asset Turnover | 0.67x |
| Receivables Turnover | 8.57x |
Taxes
Income tax took 24.67% of pretax income over the last 12 months.
| Income Tax (TTM) | $16.32M |
|---|---|
| Effective Tax Rate | 24.67% |
Scores
USPH has an Altman Z-Score of 2.81, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.81 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $837.63M over the last 12 months is up 10.40% from the 12 months before.
| Revenue | $837.63M |
|---|---|
| Revenue Growth (YoY) | +10.40% |
| Gross Profit | $334.32M |
| Operating Income | $76.30M |
| Pretax Income | $66.13M |
| Net Income | $49.81M |
| EBITDA | $99.83M |
| EBIT | $76.56M |
| Reported EPS (TTM) | $2.68 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 33.02% of the $1.30B in total assets.
| Cash and Equivalents | $38.23M |
|---|---|
| Total Debt | $246.10M |
| Net Debt | $207.88M |
| Net Debt Per Share | $13.93 |
| Working Capital | $45.54M |
| Shareholder Equity | $429.30M |
| Book Value Per Share | $28.76 |
| Tangible Book Value | -$483.87M |
| Total Assets | $1.30B |
| Total Liabilities | $508.36M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $19.74M of capital spending, operating cash flow left $69.10M of free cash flow.
| Operating Cash Flow | $88.83M |
|---|---|
| Capital Expenditures | $19.74M |
| Free Cash Flow | $69.10M |
| FCF Per Share | $4.63 |
| Depreciation and Amortization | $23.27M |
| Dividends Paid | $49.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 9.11%, against a 5-year average of 10.67%.
| Gross Margin | 39.91% |
|---|---|
| Operating Margin | 9.11% |
| Pretax Margin | 7.90% |
| Net Margin | 5.95% |
| EBITDA Margin | 11.92% |
| EBIT Margin | 9.14% |
| FCF Margin | 8.25% |
| Gross Margin (5Y Average) | 40.77% |
| Operating Margin (5Y Average) | 10.67% |
| Net Margin (5Y Average) | 7.98% |
Growth
Revenue grew 12.19% a year over 3 years, and EPS fell 1.12% a year.
| Revenue Growth (3Y CAGR) | +12.19% |
|---|---|
| Revenue Growth (5Y CAGR) | +13.05% |
| EPS Growth (3Y CAGR) | -1.12% |
| EPS Growth (5Y CAGR) | +1.85% |
| FCF Growth (3Y CAGR) | +6.64% |
| FCF Growth (5Y CAGR) | -7.96% |
| Operating Income Growth (3Y CAGR) | +15.13% |
| Book Value Per Share Growth (2Y CAGR) | -0.60% |
Dividends and Yields
USPH pays out 30.92% of earnings as dividends.
| Dividend Per Share (Annual) | $1.84 |
|---|---|
| Dividend Yield | 1.89% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +3.15% |
| Dividend Growth (5Y CAGR) | +41.26% |
| Payout Ratio | 30.92% |
| FCF Payout Ratio | 70.92% |
| Earnings Yield | 2.75% |
| FCF Yield | 4.75% |
| Shareholder Yield | 3.37% |
Stock Splits
The last split was a 3-for-2 forward split on Jun 29, 2001.
| Last Split Date | Jun 29, 2001 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:2 |
Peer Position
Against 8 similar companies, USPH has the 3rd highest P/E.
P/E RatioPeer median 22.6x
P/S RatioPeer median 1.3x
ROICPeer median 8.68%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +16.84%
Dividend YieldPeer median 0.00%
| P/E Ratio | 36.3x vs 22.6x median |
|---|---|
| P/S Ratio | 1.7x vs 1.3x median |
| ROIC | 8.54% vs 8.68% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +10.40% vs +16.84% median |
| Dividend Yield | 1.89% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 9.23% and EPS growth at 13.35% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +9.23% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +13.35% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About USPH
What is USPH's market cap?
U.S. Physical Therapy has a market cap of $1.49B. Its enterprise value, which adds debt and subtracts cash, is $1.69B.
What is USPH's P/E ratio?
U.S. Physical Therapy has a trailing P/E ratio of 36.3x and a forward P/E of 33.3x.
How many shares of USPH are outstanding?
U.S. Physical Therapy has 14.93M shares outstanding. The count is down 1.82% from a year earlier.
Does USPH pay a dividend?
Yes. U.S. Physical Therapy pays $1.84 a share a year, a dividend yield of 1.89%.
How much debt does USPH have?
U.S. Physical Therapy has $246.10M of total debt and $38.23M of cash and equivalents, a net debt position of $207.88M.
USPH pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors